TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 32947619

Group type: EXPERIMENTAL
Intervention: Various therapies for multiple sclerosis (10 therapies analyzed for relapses)
Number of subjects: 11180

Group type: EXPERIMENTAL
Intervention: Various therapies for multiple sclerosis (7 therapies analyzed for disability progression)
Number of subjects: 11180

Group type: EXPERIMENTAL
Intervention: All therapies except intramuscular interferon beta-1a
Number of subjects: 11180
Study: 35902868

Group type: EXPERIMENTAL
Intervention: IMRT with D1cc ≥ 55.8 Gy for brainstem
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: IMRT with D1cc ≥ 72.1 Gy for brain
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: IMRT with Dmax ≥ 36.6 Gy for eyeball
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: IMRT with Dmean ≥ 44 Gy for ipsilateral inner ear
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: IMRT with unspecified parameters for larynx
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: IMRT with unspecified parameters for dysphagia
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: IMRT with unspecified parameters for thyroid
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: IMRT with Dmean ≥ 25.8 Gy for contralateral parotid gland
Number of subjects: 74
Study: 34259458

Group type: EXPERIMENTAL
Intervention: IADPSG
Number of subjects: 921

Group type: COMPARATOR
Intervention: Carpenter-Coustan
Number of subjects: 921
Study: 32032736

Group type: EXPERIMENTAL
Intervention: ACT on Life workshop (1-day intervention)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 32
Study: 36387993

Group type: EXPERIMENTAL
Intervention: Kessler Foundation Strategy-based Training to Enhance Memory (KF-STEM™) - 8 sessions of cognitive rehabilitation training
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo control group
Number of subjects: 120
Study: 32026537

Group type: EXPERIMENTAL
Intervention: Aqueous extract of Cichorium intybus seeds (AECIS)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 150
Study: 33096027

Group type: EXPERIMENTAL
Intervention: Pembrolizumab (200 mg every 3 weeks)
Number of subjects: 148

Group type: EXPERIMENTAL
Intervention: Pembrolizumab plus radiotherapy (24 Gy in three fractions or 50 Gy in four fractions or 45 Gy in 15 fractions)
Number of subjects: 148
Study: 33099027

Group type: EXPERIMENTAL
Intervention: FAE for endometrial fluid (EF)
Number of subjects: 83

Group type: COMPARATOR
Intervention: FAE for other indications (Control)
Number of subjects: 83
Study: 32549196

Group type: EXPERIMENTAL
Intervention: Botulinum Toxin Type A (BoNT‐A)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Oral appliance (OA)
Number of subjects: 100
Study: 35975762

Group type: COMPARATOR
Intervention: Costoclavicular block (CCB) with 20 ml 0.5% ropivacaine
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Superior trunk block (STB) with 20 ml 0.5% ropivacaine
Number of subjects: 70

Group type: COMPARATOR
Intervention: Costoclavicular block (CCB)
Number of subjects: 70
Study: 33560138

Group type: EXPERIMENTAL
Intervention: Colchicine 0.5 mg daily
Number of subjects: 1522

Group type: EXPERIMENTAL
Intervention: Colchicine
Number of subjects: 1522

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1522
Study: 37436461

Group type: EXPERIMENTAL
Intervention: Early cord clamping (ECC) (< 10 s postpartum)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Delayed cord clamping (DCC) (45‐60 s postpartum)
Number of subjects: 96
Study: 34461322

Group type: EXPERIMENTAL
Intervention: Colchicine and rosuvastatin in addition to standard of care (SOC)
Number of subjects: 466

Group type: COMPARATOR
Intervention: Standard of care (SOC) alone
Number of subjects: 466
Study: 33757609

Group type: EXPERIMENTAL
Intervention: Levomilacipran (LVM)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Combined LVM and placebo groups
Number of subjects: 17
Study: 33685404

Group type: EXPERIMENTAL
Intervention: Dense V‐Net
Number of subjects: 133
Study: 32690499

Group type: EXPERIMENTAL
Intervention: FOLFIRI every 14 days until disease progression or unacceptable toxicity or for a maximum of 6 months
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: CAPTEM every 28 days until disease progression or unacceptable toxicity or for a maximum of 6 months
Number of subjects: 112
Study: 34355872

Group type: EXPERIMENTAL
Intervention: Cryotherapy
Number of subjects: 133

Group type: COMPARATOR
Intervention: Sham procedure
Number of subjects: 133
Study: 34965006

Group type: EXPERIMENTAL
Intervention: Green tea extract encapsulated chitosan microparticles (GTP) cream
Number of subjects: 29

Group type: COMPARATOR
Intervention: Placebo cream
Number of subjects: 29
Study: 36231378

Group type: EXPERIMENTAL
Intervention: Yoga and mindfulness intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Overall time effect
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Time by group effect
Number of subjects: 0
Study: 33787834

Group type: EXPERIMENTAL
Intervention: Revacept 160 mg
Number of subjects: 334

Group type: EXPERIMENTAL
Intervention: Revacept 80 mg
Number of subjects: 334

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 334
Study: 35680173

Group type: EXPERIMENTAL
Intervention: Combined metabolic medication (SINR) containing succinic acid, inosine, nicotinamide, and riboflavin, administered intravenously for 10 days followed by oral administration for 75 days
Number of subjects: 216

Group type: COMPARATOR
Intervention: Placebo, administered intravenously for 10 days followed by oral administration for 75 days
Number of subjects: 216

Group type: EXPERIMENTAL
Intervention: Combined metabolic medication (SINR)
Number of subjects: 216
Study: 34060685

Group type: EXPERIMENTAL
Intervention: Cervical manual therapy plus conventional physiotherapy
Number of subjects: 46

Group type: COMPARATOR
Intervention: Conventional physiotherapy
Number of subjects: 46
Study: 36122966

Group type: EXPERIMENTAL
Intervention: Self‐administered condition‐tailored psychoeducational intervention
Number of subjects: 418

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 418
Study: 33517762

Group type: EXPERIMENTAL
Intervention: 12-month interdisciplinary program
Number of subjects: 108
Study: 36115616

Group type: EXPERIMENTAL
Intervention: Single-injection liposomal bupivacaine brachial plexus nerve block (LB)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Interscalene catheter (ISC)
Number of subjects: 63
Study: 32979417

Group type: EXPERIMENTAL
Intervention: Metformin
Number of subjects: 217

Group type: COMPARATOR
Intervention: Insulin
Number of subjects: 217
Study: 35745210

Group type: EXPERIMENTAL
Intervention: Active beetroot juice (BJ) - 70 mL, 400 mg nitrate
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo beetroot juice (BJ) - 70 mL, 0 mg nitrate
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Active beetroot juice (BJ)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo beetroot juice (BJ)
Number of subjects: 15
Study: 34024686

Group type: EXPERIMENTAL
Intervention: Dapagliflozin (DAPA)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Glimepiride
Number of subjects: 45
Study: 32828503

Group type: EXPERIMENTAL
Intervention: Heat-treated colostrum (60°C, 60 min)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Raw colostrum
Number of subjects: 22
Study: 35109403

Group type: EXPERIMENTAL
Intervention: Comprehensive, individualized, person-centered management (CI-PCM)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual Community Care (UCC)
Number of subjects: 0
Study: 32410578

Group type: EXPERIMENTAL
Intervention: Milk feed type
Number of subjects: 398

Group type: EXPERIMENTAL
Intervention: Changes in milk feed type
Number of subjects: 398

Group type: COMPARATOR
Intervention: Matched controls from the same population
Number of subjects: 398
Study: 36454571

Group type: EXPERIMENTAL
Intervention: Wearing glasses (e.g., sunglasses) in public spaces for 2 weeks
Number of subjects: 3717

Group type: COMPARATOR
Intervention: Control group (no glasses)
Number of subjects: 3717
Study: 33823167

Group type: EXPERIMENTAL
Intervention: Busulfan/melphalan (BuMel) ASCT
Number of subjects: 146
Study: 34417920

Group type: EXPERIMENTAL
Intervention: Peer support score categories (7-10 points)
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Peer support score categories (≥ 11 points)
Number of subjects: 88
Study: 34244212

Group type: EXPERIMENTAL
Intervention: Inhibition of Scavenger Receptor B1 (SCARB1)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Deprivation of cholesterol or HDL
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Elevated dietary cholesterol
Number of subjects: 0

Group type: COMPARATOR
Intervention: Mendelian randomization analyses based on 31,000 individuals
Number of subjects: 0
Study: 32012255

Group type: EXPERIMENTAL
Intervention: Complete Response (CR)
Number of subjects: 601

Group type: COMPARATOR
Intervention: Partial Response (PR) or No Response (NR)
Number of subjects: 601

Group type: EXPERIMENTAL
Intervention: CR status in patients with PM primary site
Number of subjects: 601

Group type: EXPERIMENTAL
Intervention: CR status in patients with non-PM primary sites
Number of subjects: 601

Group type: COMPARATOR
Intervention: Resection of the end-of-therapy mass
Number of subjects: 601

Group type: EXPERIMENTAL
Intervention: Radiographic response
Number of subjects: 601
Study: 32929855

Group type: EXPERIMENTAL
Intervention: SCA 40%
Number of subjects: 10

Group type: COMPARATOR
Intervention: Vehicle (control)
Number of subjects: 10
Study: 36490202

Group type: EXPERIMENTAL
Intervention: Debiasing checklist
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Content-specific checklist
Number of subjects: 42

Group type: COMPARATOR
Intervention: No checklist
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Checklist use (both types)
Number of subjects: 42
Study: 33896812

Group type: EXPERIMENTAL
Intervention: Arthroscopic partial meniscectomy (APM)
Number of subjects: 192

Group type: EXPERIMENTAL
Intervention: Hyaluronic acid injection (HAI) with APM
Number of subjects: 192

Group type: EXPERIMENTAL
Intervention: Physical therapy (PT)
Number of subjects: 192

Group type: EXPERIMENTAL
Intervention: Hyaluronic acid injection (HAI) with PT
Number of subjects: 192

Group type: COMPARATOR
Intervention: Control (no specific intervention mentioned)
Number of subjects: 192
Study: 32075993

Group type: COMPARATOR
Intervention: Pulsed electromagnetic fields (PEMFs); specific details on dosage and duration are not available.
Number of subjects: 3

Group type: COMPARATOR
Intervention: Placebo; specific details on dosage and duration are not available.
Number of subjects: 3
Study: 36067089

Group type: EXPERIMENTAL
Intervention: Chlorthalidone (CTD)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Hydrochlorothiazide (HCTZ)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Aspirin (ASA)
Number of subjects: 34
Study: 34373298

Group type: EXPERIMENTAL
Intervention: Yoga
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioural therapy (CBT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Education
Number of subjects: 0
Study: 36152636

Group type: EXPERIMENTAL
Intervention: Faecal microbiota transplantation
Number of subjects: 42

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42
Study: 32920556

Group type: EXPERIMENTAL
Intervention: Psychoeducational program for caregivers
Number of subjects: 0

Group type: COMPARATOR
Intervention: Non-psychoeducated caregivers
Number of subjects: 0
Study: 36705750

Group type: EXPERIMENTAL
Intervention: Sodium bicarbonate (SB) supplementation (0.3 g·kg‐1 BM)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo (PLA)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Familiarisation (FAM)
Number of subjects: 11
Study: 32167433

Group type: EXPERIMENTAL
Intervention: 300 mg polyphenols extracted from seeds of red grape (Nero di Troia cultivar) (NATUR‐OX®) for 3 months (T1)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo for 3 months (T1)
Number of subjects: 50
Study: 32740283

Group type: EXPERIMENTAL
Intervention: HealthTRAC
Number of subjects: 38

Group type: COMPARATOR
Intervention: SBWC
Number of subjects: 38
Study: 36104787

Group type: EXPERIMENTAL
Intervention: tDCS combined with FCE
Number of subjects: 30

Group type: COMPARATOR
Intervention: Sham combined with FCE (control group)
Number of subjects: 30

Group type: COMPARATOR
Intervention: FCE alone
Number of subjects: 30
Study: 33764636

Group type: EXPERIMENTAL
Intervention: Sildenafil 25 mg three times per day plus guideline-recommended treatment for heart failure
Number of subjects: 80

Group type: COMPARATOR
Intervention: Guideline-recommended treatment for heart failure (ACEIs or ARBs, beta-blockers, aldosterone receptor antagonist, digoxin)
Number of subjects: 80
Study: 32320002

Group type: EXPERIMENTAL
Intervention: High oro-sensory exposure (OSE) with slow eating rate (ER)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Low oro-sensory exposure (OSE) with fast eating rate (ER)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: High oro-sensory exposure (OSE)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Low oro-sensory exposure (OSE)
Number of subjects: 60
Study: 35086247

Group type: EXPERIMENTAL
Intervention: Single para-muscular (SPM) approach
Number of subjects: 36

Group type: COMPARATOR
Intervention: Standard para limbal (SPL) approach
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Both SPM and SPL approaches
Number of subjects: 36
Study: 32618780

Group type: EXPERIMENTAL
Intervention: Ozone bagging therapy at 70 μg/mL for 10 minutes every 3 days for 21 days
Number of subjects: 27

Group type: COMPARATOR
Intervention: Standard wound care with antimicrobial dressings every 3 days for 21 days
Number of subjects: 27
Study: 34251445

Group type: EXPERIMENTAL
Intervention: Amitriptyline
Number of subjects: 205

Group type: EXPERIMENTAL
Intervention: Topiramate
Number of subjects: 205

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 205
Study: 35027821

Group type: EXPERIMENTAL
Intervention: Metaraminol
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Phenylephrine
Number of subjects: 75

Group type: COMPARATOR
Intervention: Norepinephrine
Number of subjects: 75
Study: 34463270

Group type: EXPERIMENTAL
Intervention: Eslicarbazepine
Number of subjects: 22
Study: 36039391

Group type: EXPERIMENTAL
Intervention: 5% topical minoxidil solution
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: 5% topical spironolactone solution
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: 5% topical minoxidil and spironolactone combination
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 120
Study: 35000943

Group type: EXPERIMENTAL
Intervention: NaviTip FX irrigation system
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Vibringe sonic irrigation system
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: EndoVac apical negative pressure irrigation system
Number of subjects: 90
Study: 33838737

Group type: EXPERIMENTAL
Intervention: Modified houses (improved housing with metal roofs and screened doors/windows)
Number of subjects: 805

Group type: COMPARATOR
Intervention: Unmodified houses (traditional housing)
Number of subjects: 805
Study: 32524862

Group type: EXPERIMENTAL
Intervention: Clarithromycin 500 mg two times per day for 5 days
Number of subjects: 12
Study: 35935305

Group type: EXPERIMENTAL
Intervention: Self-determination theory management
Number of subjects: 90
Study: 34330321

Group type: EXPERIMENTAL
Intervention: SurgeryPalTM (digital peri-operative cognitive-behavioral intervention)
Number of subjects: 400

Group type: COMPARATOR
Intervention: Education control
Number of subjects: 400
Study: 32199569

Group type: EXPERIMENTAL
Intervention: Understanding of AEBS trigger conditions (TCs)
Number of subjects: 800

Group type: EXPERIMENTAL
Intervention: Recognition of AEBS does not work properly
Number of subjects: 800

Group type: EXPERIMENTAL
Intervention: Recognition of AEBS works accidentally
Number of subjects: 800
Study: 36172702

Group type: EXPERIMENTAL
Intervention: Closed-loop phase using DBLG1 hybrid closed-loop solution
Number of subjects: 45
Study: 34472896

Group type: EXPERIMENTAL
Intervention: Group cognitive remediation therapy (CRT) with 8 group sessions over 2 months
Number of subjects: 270

Group type: COMPARATOR
Intervention: No treatment control
Number of subjects: 270

Group type: EXPERIMENTAL
Intervention: Group cognitive remediation therapy (CRT)
Number of subjects: 270
Study: 32697872

Group type: EXPERIMENTAL
Intervention: AI-assisted cytology
Number of subjects: 703103

Group type: COMPARATOR
Intervention: Manual reading
Number of subjects: 703103
Study: 33719084

Group type: EXPERIMENTAL
Intervention: Recombinant factor VIII Fc fusion protein (rFVIIIFc) dosed at 40 IU/kg every 2 days
Number of subjects: 0
Study: 35017617

Group type: EXPERIMENTAL
Intervention: linagliptin (5 mg) + insulin
Number of subjects: 73

Group type: COMPARATOR
Intervention: insulin alone
Number of subjects: 73
Study: 32889844

Group type: EXPERIMENTAL
Intervention: Buccal DEX gel 0.5 µg/kg
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Buccal DEX gel 0.75 µg/kg
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Buccal DEX gel 1 µg/kg
Number of subjects: 36
Study: 33086352

Group type: EXPERIMENTAL
Intervention: Detsky quality-of-reporting index (Detsky score)
Number of subjects: 285

Group type: COMPARATOR
Intervention: Multicenter RCTs
Number of subjects: 285

Group type: COMPARATOR
Intervention: Positive trials
Number of subjects: 285

Group type: EXPERIMENTAL
Intervention: Regression analysis
Number of subjects: 285

Group type: COMPARATOR
Intervention: Methodology scores
Number of subjects: 285

Group type: COMPARATOR
Intervention: Risk-of-bias assessment
Number of subjects: 285
Study: 34569457

Group type: EXPERIMENTAL
Intervention: Tummy time instruction (n = 20)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Tummy time + outpatient reinforcement (n = 21)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Standard of care (n = 23)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Tummy time >15 minutes daily
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Tummy time <15 minutes daily
Number of subjects: 64
Study: 36430138

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided adductor canal block (ACB), n = 15
Number of subjects: 31

Group type: COMPARATOR
Intervention: Placebo (1 mL of 1% lidocaine), n = 16
Number of subjects: 31
Study: 32397852

Group type: EXPERIMENTAL
Intervention: Topical phenylephrine hydrochloride
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: RJ101 (norepinephrine releasing agent)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study: 35365604

Group type: EXPERIMENTAL
Intervention: Baseline allostatic load (AL)
Number of subjects: 0

Group type: COMPARATOR
Intervention: High neighborhood socioeconomic status (nSES)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: nSES and AL
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: nSES
Number of subjects: 0
Study: 33782383

Group type: EXPERIMENTAL
Intervention: Deep brain stimulation (DBS)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Open-label stimulation with cognitive behavioural therapy (CBT)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Cognitive behavioural therapy (CBT)
Number of subjects: 9
Study: 32571327

Group type: EXPERIMENTAL
Intervention: Exercise training (balance or strength combined with endurance training) for 12 months
Number of subjects: 112

Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned, but implied as no exercise training)
Number of subjects: 112
Study: 32669717

Group type: EXPERIMENTAL
Intervention: AAV1/SERCA2a gene therapy (1 × 10^13 DNase-resistant particles)
Number of subjects: 5

Group type: COMPARATOR
Intervention: Placebo solution
Number of subjects: 5
Study: 34126984

Group type: EXPERIMENTAL
Intervention: Fluoride interventions (specific types and dosages not provided)
Number of subjects: 0
Study: 32446979

Group type: EXPERIMENTAL
Intervention: Xinyue capsule (100 mg panax quinquefolius saponins, three times a day)
Number of subjects: 1054

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1054

Group type: EXPERIMENTAL
Intervention: Xinyue capsule
Number of subjects: 1054
Study: 36259542

Group type: EXPERIMENTAL
Intervention: Ad26.RSV.preF vaccine (1 × 10^11 vp for adults, 5 × 10^10 vp for children)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Ad26.RSV.preF vaccine
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study: 34610830

Group type: EXPERIMENTAL
Intervention: Atherogenic index of plasma (AIP)
Number of subjects: 10251

Group type: EXPERIMENTAL
Intervention: AIP
Number of subjects: 10251
Study: 35185620

Group type: COMPARATOR
Intervention: NMES
Number of subjects: 15

Group type: COMPARATOR
Intervention: Exercise
Number of subjects: 15

Group type: COMPARATOR
Intervention: Control
Number of subjects: 15
Study: 33217865

Group type: EXPERIMENTAL
Intervention: Laparoscopic anterior resection (AR)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Medicine group
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Overall outcomes
Number of subjects: 29
Study: 35473351

Group type: EXPERIMENTAL
Intervention: Time-acupoints-space acupuncture (ATAS) administered weekly
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sham acupuncture
Number of subjects: 0

Group type: COMPARATOR
Intervention: Non-acupuncture
Number of subjects: 0
Study: 33439693

Group type: EXPERIMENTAL
Intervention: Atezolizumab (1,200 mg IV, day 1) plus carboplatin (AUC 5 mg/mL/min IV, day 1) and etoposide (100 mg/m2 IV, days 1-3)
Number of subjects: 403

Group type: COMPARATOR
Intervention: Placebo plus carboplatin (AUC 5 mg/mL/min IV, day 1) and etoposide (100 mg/m2 IV, days 1-3)
Number of subjects: 403

Group type: EXPERIMENTAL
Intervention: Atezolizumab plus carboplatin/etoposide
Number of subjects: 403

Group type: COMPARATOR
Intervention: Placebo plus carboplatin/etoposide
Number of subjects: 403
Study: 32381845

Group type: EXPERIMENTAL
Intervention: 1,25 dihydroxycholecalciferol (1,25 DHC)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo gel
Number of subjects: 15
Study: 35848580

Group type: EXPERIMENTAL
Intervention: Structured physiotherapy along with conventional treatment
Number of subjects: 35

Group type: COMPARATOR
Intervention: Conventional treatment
Number of subjects: 35
Study: 34599724

Group type: EXPERIMENTAL
Intervention: Low-dose-rate brachytherapy (LDR-BT)
Number of subjects: 567
Study: 36334130

Group type: EXPERIMENTAL
Intervention: rHuEPO (20 IU/kg body weight) i.v. injections
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo (isotonic saline)
Number of subjects: 30
Study: 33515707

Group type: EXPERIMENTAL
Intervention: Qizhitongluo capsule (QZTL)
Number of subjects: 622

Group type: EXPERIMENTAL
Intervention: Naoxintong (NXT)
Number of subjects: 622

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 622